| Integrative clinical genomics of metastatic cancer DR Robinson, YM Wu, RJ Lonigro, P Vats, E Cobain, J Everett, X Cao, ... Nature 548 (7667), 297-303, 2017 | 781 | 2017 |
| Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets HJ Yoon, TH Kim, Z Zhang, E Azizi, TM Pham, C Paoletti, J Lin, ... Nature nanotechnology 8 (10), 735-741, 2013 | 588 | 2013 |
| Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non–small-cell lung cancer: Cancer and … EE Vokes, JE Herndon, MJ Kelley, MG Cicchetti, N Ramnath, H Neill, ... Journal of clinical oncology 25 (13), 1698-1704, 2007 | 581 | 2007 |
| Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines N Ramnath, TJ Dilling, LJ Harris, AW Kim, GC Michaud, AA Balekian, ... Chest 143 (5), e314S-e340S, 2013 | 535 | 2013 |
| Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination J Yu, MD Green, S Li, Y Sun, SN Journey, JE Choi, SM Rizvi, A Qin, ... Nature medicine 27 (1), 152-164, 2021 | 534 | 2021 |
| Expression and mutational analysis of MET in human solid cancers PC Ma, MS Tretiakova, AC MacKinnon, N Ramnath, C Johnson, ... Genes, Chromosomes and Cancer 47 (12), 1025-1037, 2008 | 361 | 2008 |
| Reactive oxygen species in the tumor microenvironment: an overview F Weinberg, N Ramnath, D Nagrath Cancers 11 (8), 1191, 2019 | 353 | 2019 |
| Nuclear or cytoplasmic expression of survivin: what is the significance? F Li, J Yang, N Ramnath, MM Javle, D Tan International journal of cancer 114 (4), 509-512, 2005 | 338 | 2005 |
| Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model Z Zhang, H Shiratsuchi, J Lin, G Chen, RM Reddy, E Azizi, S Fouladdel, ... Oncotarget 5 (23), 12383, 2014 | 214 | 2014 |
| Ethnic differences and functional analysis of MET mutations in lung cancer S Krishnaswamy, R Kanteti, JS Duke-Cohan, S Loganathan, W Liu, ... Clinical Cancer Research 15 (18), 5714-5723, 2009 | 212 | 2009 |
| Effect of midtreatment PET/CT-adapted radiation therapy with concurrent chemotherapy in patients with locally advanced non–small-cell lung cancer: a phase 2 clinical trial FM Kong, RK Ten Haken, M Schipper, KA Frey, J Hayman, M Gross, ... JAMA oncology 3 (10), 1358-1365, 2017 | 206 | 2017 |
| Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy Q Zhang, MD Green, X Lang, J Lazarus, JD Parsels, S Wei, LA Parsels, ... Cancer research 79 (15), 3940-3951, 2019 | 173 | 2019 |
| MCM2 is an independent predictor of survival in patients with non–small-cell lung cancer N Ramnath, FJ Hernandez, DF Tan, JA Huberman, N Natarajan, AF Beck, ... Journal of clinical oncology 19 (22), 4259-4266, 2001 | 173 | 2001 |
| Matrix metalloproteinase inhibitors N Ramnath, PJ Creaven Current oncology reports 6, 96-102, 2004 | 171 | 2004 |
| Poor prognosis indicated by venous circulating tumor cell clusters in early-stage lung cancers V Murlidhar, RM Reddy, S Fouladdel, L Zhao, MK Ishikawa, ... Cancer research 77 (18), 5194-5206, 2017 | 169 | 2017 |
| A radial flow microfluidic device for ultra‐high‐throughput affinity‐based isolation of circulating tumor cells V Murlidhar, M Zeinali, S Grabauskiene, M Ghannad‐Rezaie, MS Wicha, ... Small 10 (23), 4895-4904, 2014 | 148 | 2014 |
| Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer M O’Malley, AN King, M Conte, VL Ellingrod, N Ramnath Journal of thoracic oncology 9 (7), 917-926, 2014 | 140 | 2014 |
| Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer J Yang, N Ramnath, KB Moysich, HL Asch, H Swede, SJ Alrawi, ... BMC cancer 6, 1-10, 2006 | 140 | 2006 |
| A novel serum 4-microRNA signature for lung cancer detection E Nadal, A Truini, A Nakata, J Lin, RM Reddy, AC Chang, N Ramnath, ... Scientific reports 5 (1), 12464, 2015 | 138 | 2015 |
| EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation L Faoro, PA Singleton, GM Cervantes, FE Lennon, NW Choong, R Kanteti, ... Journal of biological chemistry 285 (24), 18575-18585, 2010 | 136 | 2010 |
